Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 9:9:881630.
doi: 10.3389/fmed.2022.881630. eCollection 2022.

Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study

Affiliations

Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study

Mauricio Cristiano Rocha-Junior et al. Front Med (Lausanne). .

Abstract

Human T cell lymphotropic virus (HTLV) is the caustive agent of two main conditions i. e., the HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and the adult T-cell leukemia/lymphoma (ATLL). HTLV diagnosis is based on serological and molecular approaches; however, an accurate and validated method is still needed. The objective of this study was to establish a rapid and sensitive molecular test to confirm and discriminate HTLV 1/2 types. The test validation was performed as a multicentric study involving HTLV confirmation centers throughout Brazil. Proviral DNA was extracted from whole blood and the amplification was performed using in-house designed primer and probe sets targeting the pol genomic region. An internal control to validate the extraction and amplification was also included. The limit of detection (LoD) of the assay was four copies/reaction for HTLV-1 and 10.9 copies/reaction for HTLV-2. The diagnostic sensitivity of the platform was 94.6% for HTLV-1, 78.6% for HTLV-2, and the specificity was 100% for both viruses. Cross-reactions of the test with human viruses including HAV, HBV, HCV, HIV-1/2, and parvovirus B19 were not observed. During the multicentric validation, the test was used to screen a total of 692 blood samples obtained from previously confirmed HTLV-positive individuals. From these, 91.1% tested positive being concordant with the previously obtained results. In conclusion, our duoplex-RT-PCR-HTLV1 /2 presented adequate efficiency for HTLV-1/2 differentiation showing high sensitivity and specificity. Therefore, it can be a suitable tool for confirmation of suspected and inconclusive HTLV cases, prenatal and pre-transplant diagnosis, in Brazil and in other countries HTLV-endemic countries.

Keywords: HTLV-1; HTLV-2; molecular diagnosis; multiplex real time PCR; real time PCR.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Amplification plots and standard curves of singleplex and multiplex assays. Singleplex format is demonstrated for (A,B) HTLV-1, (C,D) HTLV-2, and (E,F) internal control, beta-globin. (G,H) Multiplex format for the three targets HTLV-1, HTLV-2, and beta globin. Serial decimal dilutions ranging from 105 to 100 copies/reaction were used in the qPCR reactions. DNA from MT-2 and Gu cell lines were used as positive samples for HTLV-1 and HTLV-2, respectively.

Similar articles

Cited by

References

    1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. (1980) 77:7415–9. 10.1073/pnas.77.12.7415 - DOI - PMC - PubMed
    1. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science. (1982) 218:571–3. 10.1126/science.6981847 - DOI - PubMed
    1. Calattini S, Chevalier SA, Duprez R, Bassot S, Froment A, Mahieux R, et al. . Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology. (2005) 2:30. 10.1186/1742-4690-2-30 - DOI - PMC - PubMed
    1. Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, et al. . Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci USA. (2005) 102:7994–9. 10.1073/pnas.0501734102 - DOI - PMC - PubMed
    1. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, et al. . Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. (1985) 2:407–10. 10.1016/S0140-6736(85)92734-5 - DOI - PubMed